Biotech entity
pharma is the sole category represented across all 1 tracked stories. Michael Barr is most often covered alongside Federal Reserve, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Michael Barr, all published on February 18, 2026.
Last mentioned: Aug 14, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Michael Barr is most often covered alongside Federal Reserve, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Michael Barr, all published on February 18, 2026. Each carries 28 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Michael Barr. Shared-story counts are live from our verified record — not editorial picks.
US equities faced a volatile session as investors reassessed the 'dark side' of AI disruption, dragging the Nasdaq into its fifth consecutive week of losses. Within the healthcare sector, attention is fixed on Medtronic's earnings and Masimo's performance as the industry grapples with shifting valuations.
Source: Benzinga · Yahoo Finance
Michael Barr is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
